As the prevalence of mental health disorders continues to rise, the need for effective treatments has never been more critical. One such treatment that has garnered attention is Lexapro, a selective serotonin reuptake inhibitor (SSRI) commonly prescribed for depression and anxiety disorders. In this article, we will explore the insights shared at a recent medical conference focused on the problems that Lexapro addresses, and how healthcare professionals can better assist patients seeking to order Lexapro for their treatment.